Bank of New York Mellon’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Bank of New York Mellon’s Portfolio AXLA Stock Details AXLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,743	Closed	-$9.51K	–	4435
2023 Q2	$9.51K	Hold	1,743	–	–	﹤0.01%	4345
2023 Q1	$20.9K	Hold	1,743	–	–	﹤0.01%	4305
2022 Q4	$14.3K	Hold	1,743	–	–	﹤0.01%	4388
2022 Q3	$75K	Hold	1,743	–	–	﹤0.01%	4255
2022 Q2	$89K	Hold	1,743	–	–	﹤0.01%	4251
2022 Q1	$112K	Hold	1,743	–	–	﹤0.01%	4387
2021 Q4	$91K	Hold	1,743	–	–	﹤0.01%	4413
2021 Q3	$129K	Hold	1,743	–	–	﹤0.01%	4284
2021 Q2	$175K	Sell	1,743 -1,688	-49%	-$167K	﹤0.01%	4127
2021 Q1	$409K	Sell	3,431 -54	-2%	-$7.62K	﹤0.01%	3795
2020 Q4	$453K	Buy	3,485 +2,084	+149%	+$268K	﹤0.01%	3666
2020 Q3	$162K	Sell	1,401 -61	-4%	-$7.52K	﹤0.01%	3888
2020 Q2	$202K	Buy	1,462 +492	+51%	+$60.2K	﹤0.01%	3794
2020 Q1	$83K	Buy	970 +175	+22%	+$17.9K	﹤0.01%	3889
2019 Q4	$80K	Buy	+795	New	+$87.4K	﹤0.01%	4050

Other funds holding AXLA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon's AXLA Position: Q3 2023 in Review

Bank of New York Mellon sold out of Axcella Health Inc. Common Stock (AXLA) in Q3 2023, closing a stake of 1,743 shares — an estimated $9.51K sold.

Bank of New York Mellon first reported a position in AXLA in Q4 2019 and held it in 15 quarters. The position peaked at $453K in Q4 2020. 15 funds tracked by Wall St. Rank hold AXLA as of Q3 2023.

Bank of New York Mellon reported no remaining Axcella Health Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bank of New York Mellon sold 1,743 Axcella Health Inc. Common Stock shares in Q3 2023, an estimated $9.51K.
Bank of New York Mellon first reported a position in Axcella Health Inc. Common Stock in Q4 2019 and held it in 15 quarters.
Bank of New York Mellon's Axcella Health Inc. Common Stock position peaked at $453K in Q4 2020.
15 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q3 2023.

Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.